Loading
Just as clinical trials must be registered before they start, studies using hospital data should be registered too, so the failed or unwelcome ones cannot quietly disappear.
Real-world studies are prone to selective reporting and analytic flexibility; there is no registration requirement. The proposal creates a registry for observational oncology studies (protocol, analysis plan, data source, funder) with results deposition within 12 months, required by journals, regulators considering RWE, and funders. The EU PAS register and the RWE Transparency Initiative are partial precedents.
Shares Preclinical results do not reproduce, Real-world evidence.
Shares Real-world evidence, Weak real-world evidence and registries.
Shares Real-world evidence, Weak real-world evidence and registries.
Shares Real-world evidence, Weak real-world evidence and registries.
Shares Real-world evidence, Weak real-world evidence and registries.
Shares Real-world evidence, Failures are hidden, Weak real-world evidence and registries.
Shares Real-world evidence, Weak real-world evidence and registries.
Shares Real-world evidence, Weak real-world evidence and registries.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/